Severe reaction to Moderna vaccine 'rare' — US study
This file photo taken on November 18, 2020 shows a syringe and a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. American experts were set to discuss on December 17, 2020 if Moderna's Covid-19 vaccine should be authorized, as European nations vowed to get their coronavirus inoculation campaigns rolling before the end of the year. Surges in infections have prompted tighter restrictions in several European countries, while the United States -- the worst-hit nation in the world -- set a double record, with more than 3,700 deaths and 250,000 new cases in 24 hours on December 16, 2020.
AFP/Joel Saget

Severe reaction to Moderna vaccine 'rare' — US study

(Agence France-Presse) - January 23, 2021 - 9:36am

WASHINGTON, United States — Severe allergic reaction to Moderna's COVID-19 vaccine is "rare," US health authorities said Friday, with only 10 cases arising from more than four million first doses.

The Centers for Disease Control and Prevention also emphasized that widespread vaccination was critical to fighting the coronavirus pandemic.

"Based on this early monitoring, anaphylaxis after receipt of Moderna COVID-19 vaccine appears to be a rare event," the CDC said in a report, indicating that none of the reactions resulted in death.

The CDC data documented the 10 cases of anaphylactic shock among a reported 4,041,396 first doses administered between December 21 and January 10.

They were recorded among 108 possible allergic reactions, the CDC said, with six of the cases requiring hospitalization, while the other four were treated in an emergency department setting.

The numbers represent 2.5 cases of anaphylactic shock per one million Moderna injections, compared with 11.1 cases per one million Pfizer injections, according to the CDC study.

"The clinical and epidemiologic characteristics of anaphylaxis case reports after receipt of Moderna COVID-19 vaccine are similar to those reported after receipt of the Pfizer-BioNTech COVID-19 vaccine," the CDC said.

Of the 10 severe cases, all were women, aged 31 to 63, and nine had a history of prior allergic reaction, although not to vaccines.

A heavily female ratio was also noted with the Pfizer vaccine, which experts say could be due to the fact that more women than men have been vaccinated, at a rate of approximately two to one.

Symptoms began within 15 minutes after injection for nine of the Moderna shot recipients, and after 30 minutes for one.

Vaccination sites must be equipped and able to treat severe allergic reaction, and able to transport patients to the hospital if necessary, the CDC said.

"Widespread vaccination against COVID-19 with highly effective vaccines represents a critical tool in efforts to control the pandemic and save lives," the agency added.

  • Latest
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with